Equifax Inc.
182.36USD
-4.7800 (-2.55%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on EFX.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.13▼ | $2.23 | 0 | 5 |
| Next quarter | $1.93▼ | $2.14 | 0 | 3 |
| Current year | $8.5▼ | $8.56 | 0 | 8 |
| Next year | $9.57▼ | $10.11 | 0 | 8 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-09-30 | $2.2 | $2.26 | +0.06 (+2.8%) |
| 2026-06-30 | $2.2 | $2.25 | +0.05 (+2.3%) |
| 2026-03-31 | $1.7 | $1.86 | +0.16 (+9.7%) |
| 2025-12-31 | $2.05 | $2.09 | +0.04 (+1.8%) |
336 ratings from 33 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Argus Research | Upgraded from Hold | Buy | — | Oct 22, 2026 |
| BMO Capital | Maintained | Market Perform | $160 $175 | Oct 21, 2026 |
| Stifel | Maintained | Buy | $235 $217 | Oct 21, 2026 |
| Needham | Maintained | Buy | $190 $210 | Oct 21, 2026 |
| Mizuho | Maintained | Outperform | $210 $185 | Oct 19, 2026 |
| Oppenheimer | Downgraded from Outperform | Perform | — | Oct 16, 2026 |
| RBC Capital | Maintained | Outperform | $194 $177 | Oct 16, 2026 |
| Morgan Stanley | Maintained | Overweight | $225 $205 | Oct 13, 2026 |
| Needham | Maintained | Buy | $245 $190 | Oct 13, 2026 |
| Barclays | Maintained | Equal-Weight | $200 $155 | Oct 2, 2026 |
| BMO Capital | Maintained | Market Perform | $179 $160 | Sep 30, 2026 |
| Wells Fargo | Maintained | Overweight | $212 $200 | Sep 22, 2026 |
| Rothschild & Co | Upgraded from Neutral | Buy | $214 $235 | Aug 21, 2026 |
| Wells Fargo | Maintained | Overweight | $220 $212 | Jul 22, 2026 |
| Morgan Stanley | Maintained | Overweight | $243 $225 | Jul 22, 2026 |
| Baird | Maintained | Outperform | $245 $232 | Jul 22, 2026 |
| RBC Capital | Maintained | Outperform | $222 $194 | Jul 22, 2026 |
| Barclays | Maintained | Equal-Weight | $215 $200 | Jul 22, 2026 |
| Needham | Maintained | Buy | $265 $245 | Jul 22, 2026 |
| UBS | Reiterated | Buy | $220 | Jul 8, 2026 |
| Needham | Reiterated | Buy | $265 | Jul 7, 2026 |
| Mizuho | Maintained | Outperform | $222 $210 | Jul 2, 2026 |
| UBS | Maintained | Buy | $215 $220 | Jul 2, 2026 |
| Wells Fargo | Maintained | Overweight | $230 $220 | Jun 18, 2026 |
| UBS | Maintained | Buy | $212 $215 | Jun 16, 2026 |
104 filings from 25 insiders · 11 buy / 5 sell over 6m
Officers and directors of EFX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| MARCUS ROBERT DDirector | GrantPhantom Stock Units | 255 | $137.24 | $35k | Sep 30, 2026 |
| Larson Barbara ADirector | GrantPhantom Stock Units | 209 | $137.24 | $29k | Sep 30, 2026 |
| GAMBLE JOHN W JROfficer, EVP, CFO & COO | Sell | 4.5k | $187.96 | $846k | Sep 3, 2026 |
| BEGOR MARK W.Chief Executive Officer | Exercise | 37.8k | $112.46 | $4.25M | Jul 24, 2026 |
| BEGOR MARK W.Chief Executive Officer | Sell | 37.8k | $168.47 | $6.51M | Jul 24, 2026 |
| BORTON CHAD MOfficer | Sell | 2.5k | $173.89 | $427k | May 7, 2026 |
| SMITH MELISSA DEEDirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| MARCUS ROBERT DDirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| MCKINLEY JOHN A JRDirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| MCGREGOR SCOTT ADirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| FEIDLER MARK LDirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| LARSON BARBARA ADirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| FICHUK KAREN LINNDirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| TILLMAN AUDREY BOONEDirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| HOUGH G THOMASDirector | Grant | 1.3k | $175.62 | $220k | May 7, 2026 |
| GAMBLE JOHN W JRChief Operating Officer | Sell | 3.5k | $176.54 | $618k | May 1, 2026 |
| BEGOR MARK W.Chief Executive Officer | Exercise | 37.8k | $112.46 | $4.25M | Apr 24, 2026 |
| BEGOR MARK W.Chief Executive Officer | Sell | 37.8k | $171.57 | $6.52M | Apr 24, 2026 |
| SMITH DAVID JOHNOfficer | Grant | 23.0k | — | — | Mar 2, 2026 |
| BEGOR MARK W.Chief Executive Officer | Grant | 41.0k | — | — | Feb 25, 2026 |
No analyst notes on EFX yet.
Analyst Ratings
20 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 13 | 6 | 0 | 0 | Buy2.04 |
| 1 mo ago | 6 | 13 | 5 | 0 | 0 | Buy1.96 |
| 2 mo ago | 4 | 13 | 7 | 0 | 0 | Buy2.13 |
| 3 mo ago | 4 | 12 | 8 | 0 | 0 | Buy2.17 |
Members whose judged calls on EFX have played out most reliably.
No settled calls on EFX yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice